First Implant of KingstronBio's ProStyle M® Transcatheter Mitral Valve System Successfully Completed in National Multicenter Confirmatory Study

Trial StartProStyle M® Transcatheter Mitral Valve SystemPositive

AI Analysis

Summary

KingstronBio completed the first successful implant of its ProStyle M® Transcatheter Mitral Valve System under ultrasound guidance as part of a national multicenter confirmatory study on March 12, 2026.

Clinical Trial Data

Outcome Details

First implant successfully completed under ultrasound guidance

Importance:5/10

Sentiment:

0.60

medical devicetranscatheter mitral valveclinical trialfirst implantconfirmatory study

Related Companies

$NHPAP $TRAX

Read the original article

Published by PR Newswire Biotech on April 8, 2026 2:41 PM

Read Original